EW
Edwards Lifesciences Corporation
NYQ
$85.11
-0.65
(-0.76%)
Neutral · -0.06σ
Quarterly financials
last 7 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.65B | $1.29B | $514.7M | $380.7M | $-21.1M | 78.0% | 31.2% | 23.1% |
| 2025-12-31 | $1.57B | $1.23B | $370.3M | $91.2M | $353.5M | 78.1% | 23.6% | 5.8% |
| 2025-09-30 | $1.55B | $1.21B | $425.1M | $291.1M | $516.2M | 77.8% | 27.4% | 18.7% |
| 2025-06-30 | $1.53B | $1.19B | $430.9M | $329.8M | $240.9M | 77.5% | 28.1% | 21.5% |
| 2025-03-31 | $1.41B | $1.11B | $409.9M | $358.0M | $224.4M | 78.7% | 29.0% | 25.3% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |
| 2024-09-30 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |